SCHEMBL6408035

SCHEMBL6408035

COc1ccc(C(=O)NCc2cc(CC(C)C)no2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.51
MEN1 O00255 4/20 0.51
MAPK1 P28482 1/20 0.51
NPC1 O15118 7/20 0.50
RAB9A P51151 6/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
ALDH1A1 P00352 4/20 0.50
CYP1A2 P05177 1/20 0.50
POLB P06746 3/20 0.48
SLC5A7 Q9GZV3 1/20 0.48
HPGD P15428 2/20 0.48
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
MAPT P10636 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
USP2 O75604 1/20 0.46
PPARG P37231 1/20 0.46
GAA P10253 1/20 0.46
EPHX2 P34913 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404219 0.89 ALDH1A1 (0.58) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL6407570 0.87 RAB9A (0.59) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL6404261 0.87 TDP1 (0.50) KMT2AMEN1MAPK1NPC1RAB9A
SCHEMBL6403020 0.86 NPC1 (0.52) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL6409982 0.86 KMT2A (0.53) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL6405222 0.86 SMN1; SMN2 (0.59) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL6403585 0.86 SMN1; SMN2 (0.55) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL6404133 0.85 KMT2A (0.52) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL6403186 0.85 KMT2A (0.53) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL6407402 0.85 ALDH1A1 (0.54) KMT2AMEN1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050171358-A1 Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide SDS BIOTECH K.K. (JP) 2005-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171358-A1 Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide AHR, ERG28, CYP1A2 KMT2A 986/4885MEN1 3154/4885MAPK1 2993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.